INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
GB
Gozlan Lawrence BernardDirector
ATHEALTERITY THERAPEUTICS LTD
Grant or award
A—
1.00M sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC Form 4

Evidence

19
CA
Castetter AndreaEVP, GC, Sec'y & CCO
NOTVInotiv, Inc.
Tax withholding
F$107
5,800 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

19
CS
Cherwoo ShardaDirector
WKCWORLD KINECT CORP
Grant or award
A—
6,427 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

19
SV
Sriram VandanaChief Financial Officer
QTRXQuanterix Corp
Option exercise
M—
514 sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC Form 4

Evidence

19
SV
Sriram VandanaChief Financial Officer
QTRXQuanterix Corp
Tax withholding
F$977
315 sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC Form 4

Evidence

19
SV
Sriram VandanaChief Financial Officer
QTRXQuanterix Corp
Option exercise
M—
1,056 sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC Form 4

Evidence

19
FB
Freeman Jeffrey BrennanVP-Finance & Corp. Controller
NOTVInotiv, Inc.
Tax withholding
F$108
5,855 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

19
SV
Sriram VandanaChief Financial Officer
QTRXQuanterix Corp
Option exercise
M—
1,056 sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC Form 4

Evidence

18
AG
Ariqat GhassanExecutive Vice President
TPCTUTOR PERINI CORP
Tax withholding
F$1.04M
13.3K sh
Jun 19, 2026Jun 23, 2026
traded Jun 19, 2026
+4dSEC Form 4

Evidence

18
Sylebra Capital LlcDirector, 10% Owner
AEVAAeva Technologies, Inc.
Grant or award
A$150K
6,150 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

18
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$125K
17.6K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

18
BL
Brown Claude LeonardChief Business Officer
PINSPINTEREST, INC.
Tax withholding
F$1.29M
63.8K sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

17
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$101K
280 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
TN
Thornberry NancyDirector
SDGRSchrodinger, Inc.
Grant or award
A—
8,141 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
KP
Krawiec PeterDirector
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
17.4K sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$69K
190 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$174K
480 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$156K
435 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
1,000 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

17
KR
Kapeller-Libermann RosanaDirector
SDGRSchrodinger, Inc.
Grant or award
A—
8,141 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

17
DH
Dieu HenrySVP & Chief Accounting Officer
TPCTUTOR PERINI CORP
Tax withholding
F$41K
522 sh
Jun 19, 2026Jun 23, 2026
traded Jun 19, 2026
+4dSEC Form 4

Evidence

16
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,164
774 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

15
MD
Mitchell Hardin DeanEVP, CFO and Treasurer
ACTEnact Holdings, Inc.
Grant or award
A—
58 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
8 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
SE
Stolove EvanEVP, Gen. Counsel & Secretary
ACTEnact Holdings, Inc.
Grant or award
A—
28 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
BA
Bless Michael ADirector
ACTEnact Holdings, Inc.
Grant or award
A—
176 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
GB
Gould BrianEVP & Chief Operations Officer
ACTEnact Holdings, Inc.
Grant or award
A—
19 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
DM
Derstine MichaelEVP and Chief Risk Officer
ACTEnact Holdings, Inc.
Grant or award
A—
15 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
FT
Fuchs ThomasDirector
WGSGeneDx Holdings Corp.
Grant or award
A—
4,248 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MD
Mitchell Hardin DeanEVP, CFO and Treasurer
ACTEnact Holdings, Inc.
Grant or award
A—
36 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
GR
Gupta RohitDirector, President and CEO
ACTEnact Holdings, Inc.
Grant or award
A—
107 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
WM
Williams John MoganSenior Vice President
BHBBAR HARBOR BANKSHARES
Grant or award
A$2,832
78 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
10 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
WM
Williams John MoganSenior Vice President
BHBBAR HARBOR BANKSHARES
Grant or award
A$110
3 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
4 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
GR
Gupta RohitDirector, President and CEO
ACTEnact Holdings, Inc.
Grant or award
A—
173 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
SD
Still DebraDirector
ACTEnact Holdings, Inc.
Grant or award
A—
201 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
15 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
ME
Mitchell H ElizabethDirector
ACTEnact Holdings, Inc.
Grant or award
A—
56 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
HG
Hrustanovic GorjanDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

Page 652 of 1737
← PrevNext →